Nivolumab vs Tamoxifen

## Nivolumab vs Tamoxifen: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Tamoxifen**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Tamoxifen**: Selective estrogen receptor modulator (SERM).

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Tamoxifen — 5-7 days.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Tamoxifen — C26H29NO.

**Molecular Weight**: Nivolumab — N/A; Tamoxifen — 371.5150 g/mol.

**Type**: Nivolumab — Antibody; Tamoxifen — Small molecule.